EASIX and modified-EASIX are early predictors of severe cytokine release syndrome and neurotoxicity in patients treated with chimeric antigen receptor T cells Meeting Abstract

  

Authors:	Pennisi, M.; Sanchez-Escamilla, M.; Flynn, J.; Maloy, M. A.; Silverberg, M. L.; Batlevi, Y.; Shouval, R.; Batlevi, C. L.; Brentjens, R. J.; Devlin, S. M.; Dahi, P. B.; Diamonte, C.; Giralt, S. A.; Halton, E.; Jain, T.; Mead, E.; Palomba, M. L.; Santomasso, B.; Sauter, C. S.; Scordo, M.; Shah, G. L.; Park, J. H.; Perales, M. A.
Abstract Title:	EASIX and modified-EASIX are early predictors of severe cytokine release syndrome and neurotoxicity in patients treated with chimeric antigen receptor T cells
Meeting Title:	61st Annual Meeting and Exposition of the American Society of Hematology (ASH)
Journal Title:	Blood
Volume:	134
Issue:	Suppl. 1
Meeting Dates:	2019 Dec 7-10
Meeting Location:	Orlando, FL
ISSN:	0006-4971
Publisher:	American Society of Hematology
Date Published:	2019-11-13
Language:	English
ACCESSION:	WOS:000577160403220
DOI:	10.1182/blood-2019-126208
PROVIDER:	wos
Notes:	Meeting Abstract: 1947 -- Source: Wos

https://synapse.mskcc.org/synapse/works/has_related_data_chk/175734